Archive for February 2024

Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB)   Xylazine: Still a Threat In April 2023, Xylazine was designated as an emerging threat to the United States after a series of reports from the FDA (Food and Drug Administration) and DEA (Drug Enforcement Administration). (1) While the dangers of Xylazine have been documented, the prevalence of…